Glomerulonephritis

Harbour BioMed’s WIN378 Shows Positive Phase 2 Asthma Data

Cambridge, Massachusetts, U.S.; Rotterdam, Netherlands; and Shanghai, China, September 8, 2026 Harbour BioMed has announced positive interim results from...

By cGxPwire Editor
September 9, 2026

Pharma

Alebund’s AP308 Gets FDA IND Clearance for IgA Nephropathy

Shanghai, China, September 8, 2026 Alebund Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has cleared...

By cGxPwire Editor
September 9, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Glomerulonephritis

Harbour BioMed’s WIN378 Shows Positive Phase 2 Asthma Data

Alebund’s AP308 Gets FDA IND Clearance for IgA Nephropathy